Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie E B McArdle

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Biomedicines|February 15, 2018
Immune Landscape of Breast CancersDivya Nagarajan, Stephanie E B McArdle
Frontiers in Immunology|May 8, 2024
Editorial: Improving responses to immunotherapy in glioblastoma multiformeStephanie E B McArdle, Divya Nagarajan, Michael E Barish
Frontiers in Immunology|November 1, 2021
Editorial: Frontiers' Research Topic "Cancer Vaccines: Time to Think Differently!"Stephanie E B McArdle, Graham Pawelec, Alan Graham Pockley, et al.
Methods in Molecular Medicine|May 3, 2003
Phenotypic and functional differences of dendritic cells generated under different in vitro conditionsStephanie E B McArdle, Selman A Ali, Geng Li, et al.
Frontiers in Immunology|March 8, 2021
Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and TreatmentsStefania Cuzzubbo, Sara Mangsbo, Divya Nagarajan, et al.
Cancer Immunology, Immunotherapy : CII|March 5, 2009
Tumour antigen-targeted immunotherapy for chronic myeloid leukaemia: is it still viable?Catherine L Riley, Morgan G Mathieu, Richard E Clark, et al.
Cancer Immunology, Immunotherapy : CII|March 24, 2006
The role of CD4+ T cell help in cancer immunity and the formulation of novel cancer vaccinesDeepak P Assudani, Roger B V Horton, Morgan G Mathieu, et al.
Current Pharmaceutical Design|October 27, 2005
Immunity to tumour antigensGeng Li, Selman A Ali, Stephanie E B McArdle, et al.
The Journal of Biological Chemistry|March 7, 2012
The helicase HAGE expressed by malignant melanoma-initiating cells is required for tumor cell proliferation in vivoAdam J Linley, Morgan G Mathieu, Amanda K Miles, et al.
The Prostate|May 15, 2003
Disabled infectious single cycle herpes simplex virus (DISC-HSV) is a candidate vector system for gene delivery/expression of GM-CSF in human prostate cancer therapyRichard J Parkinson, Shahid Mian, Michael C Bishop, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Biomedicines|February 15, 2018
Immune Landscape of Breast CancersDivya Nagarajan, Stephanie E B McArdle
Frontiers in Immunology|May 8, 2024
Editorial: Improving responses to immunotherapy in glioblastoma multiformeStephanie E B McArdle, Divya Nagarajan, Michael E Barish
Frontiers in Immunology|November 1, 2021
Editorial: Frontiers' Research Topic "Cancer Vaccines: Time to Think Differently!"Stephanie E B McArdle, Graham Pawelec, Alan Graham Pockley, et al.
Methods in Molecular Medicine|May 3, 2003
Phenotypic and functional differences of dendritic cells generated under different in vitro conditionsStephanie E B McArdle, Selman A Ali, Geng Li, et al.
Frontiers in Immunology|March 8, 2021
Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and TreatmentsStefania Cuzzubbo, Sara Mangsbo, Divya Nagarajan, et al.
Cancer Immunology, Immunotherapy : CII|March 5, 2009
Tumour antigen-targeted immunotherapy for chronic myeloid leukaemia: is it still viable?Catherine L Riley, Morgan G Mathieu, Richard E Clark, et al.
Cancer Immunology, Immunotherapy : CII|March 24, 2006
The role of CD4+ T cell help in cancer immunity and the formulation of novel cancer vaccinesDeepak P Assudani, Roger B V Horton, Morgan G Mathieu, et al.
Current Pharmaceutical Design|October 27, 2005
Immunity to tumour antigensGeng Li, Selman A Ali, Stephanie E B McArdle, et al.
The Journal of Biological Chemistry|March 7, 2012
The helicase HAGE expressed by malignant melanoma-initiating cells is required for tumor cell proliferation in vivoAdam J Linley, Morgan G Mathieu, Amanda K Miles, et al.
The Prostate|May 15, 2003
Disabled infectious single cycle herpes simplex virus (DISC-HSV) is a candidate vector system for gene delivery/expression of GM-CSF in human prostate cancer therapyRichard J Parkinson, Shahid Mian, Michael C Bishop, et al.
Pageof 3